Categories AlphaGraphs, Earnings, Health Care

Key highlights from AngioDynamics (ANGO) Q4 2020 earnings results

AngioDynamics, Inc. (NASDAQ: ANGO) today announced its fourth quarter financial results for the period ended May 31, 2020.

  • Net loss for the fourth quarter was $156 million, or $4.10 per share, compared to net loss of $165.8 million, or $4.37 per share in the fourth quarter of 2019
  • Net sales decreased 41% to $58.3 million
  • Capital expenditures during the quarter was $1.5 million

Looking forward to listening to management/analysts comments on Q4 results? Stay tuned here for AngioDynamics Q4 2020 earnings call transcript


AngioDynamics Reports Fiscal 2020 Fourth Quarter and Full-Year Financial Results

Most Popular

AAPL Earnings: Apple’s Q2 sales and profit beat estimates; iPhone sales down 10%

Apple Inc. (NASDAQ: AAPL) on Thursday reported better-than-expected profit and revenue for the second quarter of 2024. There was a 10% decrease in iPhone sales. The gadget giant reported revenues

Shopify (SHOP) is all set to report Q1 2024 results. Here’s what to expect

Over the years, Shopify Inc. (NYSE: SHOP) has steadily expanded its footprint in the online retail market through constant innovation, like the recent launch of a mobile POS device for

eBay (EBAY): A look at how the ecommerce company fared in Q1 2024

Shares of eBay Inc. (NASDAQ: EBAY) were down over 2% on Thursday. The company reported its earnings results for the first quarter of 2024 a day ago, with revenue and

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top